Accurate quantification of tetanus neurotoxin-induced focal spasticity in mice using complex running wheels

Journal of Neuroscience Methods

Volumn 205, Issue 1, 2012, Pages 45-48

  Kutschenko, Anna ^a   Reinert, Marie Christine ^a   Klinker, Florian ^a   Paulus, Walter ^a   Hesse, Stefan ^b   Liebetanz, David ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

In vivo test; Mice; Rehabilitation; Spasticity; Tetanus neurotoxin; Wheel running

Indexed keywords

TETANUS NEUROTOXIN; TETANUS TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; IN VIVO STUDY; MALE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; RAT; RUNNING; SPASTICITY; SYMPTOM; TIBIALIS ANTERIOR MUSCLE; VELOCITY; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOMECHANICS; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; MALE; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MOTOR NEURONS; MUSCLE SPASTICITY; MUSCLE TONUS; MUSCLE, SKELETAL; PARALYSIS; RUNNING; TETANUS TOXIN;

EID: 84855906506     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.12.019     Document Type: Article

References (15)

1. Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Huffman J.W., et al. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000, 404:84-87.
2. Behrensdorf-Nicol H.A., Bonifas U., Kegel B., Silberbach K., Krämer B., Weisser K. In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step. Toxicol In Vitro 2010, 24:988-994.
3. Council of Europe. Tetanus Vaccine (adsorbed). European Pharmacopoeia, sixth ed. Monography 0452; 2008.
4. Fellows S.J., Kaus C., Thilmann A.F. Voluntary movement at the elbow in spastic hemiparesis. Ann Neurol 1994, 36:397-407.
5. Fishman P.S., Parks D.A., Bowen T., Matthews C.C. Localized tetanus in immunized mice. Neurotoxicology 2009, 30:697-701.
6. Goonetilleke A., Harris J.B. Clostridial neurotoxins. J Neurol Neurosurg Psychiatry 2004, (Suppl 3):iii35-iii39.
7. Horstman A.M., Beltman M.J., Gerrits K.H., Koppe P., Janssen T.W., Elich P., et al. Intrinsic muscle strength and voluntary activation of both lower limbs and functional performance after stroke. Clin Physiol Funct Imaging 2008, 28:251-261.
8. Kutschenko A, Reinert MC, Klinker F, Paulus W, Hesse S, Liebetanz D. Botulinum toxin-induced focal paresis in mice is unaffected by muscle activity. Muscle Nerve, doi:10.1002/mus.22210.
9. Liebetanz D., Merkler D. Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 2006, 202:217-224.
10. Liebetanz D., Baier P.C., Paulus W., Meuer K., Bähr M., Weishaupt J.H. A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease. Exp Neurol 2007, 205:207-213.
11. Robinson J.F. Purification of tetanus toxin and its major peptides. Methods Enzymol 1988, 165:85-90.
12. Rossetto O., Seveso M., Caccin P., Schiavo G., Montecucco C. Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 2001, 39:27-41.
13. Sanders I. Method for using tetanus toxin for beneficial purposes in animals (mammals). US Patent. Application. Publication. Pub No. US2004/248188A1; 2004.
14. Sasse A., Conduit R., Ryan D., Woods W., Tucker A.P. A pharmacotherapy for obstructive sleep apnea. Sleep 2005, 28:1015-1016.
15. Webster R.A., Laurence D.R. The effect of antitoxin on fixed and free toxin in experimental tetanus. J Pathol Bacteriol 1963, 86:413-420.